BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Abenavoli L, Masarone M, Peta V, Milic N, Kobyliak N, Rouabhia S, Persico M. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3. World J Gastroenterol 2014; 20(41): 15233-15240 [PMID: 25386071 DOI: 10.3748/wjg.v20.i41.15233]
URL: https://www.wjgnet.com/1007-9327/full/v20/i41/15233.htm
Number Citing Articles
1
Dina G. Tiniakos, Quentin M. Anstee, Alastair D. Burt. Macsween's Pathology of the Liver2018; : 308 doi: 10.1016/B978-0-7020-6697-9.00005-4
2
Renata D. Giustina, Maíra L. Marconcini, Emilia T.O. Bansho, Débora Tonon, Ana P.B.F. Pasinato, Esther B. Dantas-Corrêa, Leonardo L. Schiavon, Janaína L. Narciso-Schiavon. Factors associated with steatosis in liver biopsies of individuals with chronic hepatitis C infection in southern BrazilArab Journal of Gastroenterology 2015; 16(2): 59 doi: 10.1016/j.ajg.2015.06.002
3
Ratna B. Ray, Ranjit Ray. Hepatitis C Virus Manipulates Humans as its Favorite Host for a Long‐Term RelationshipHepatology 2019; 69(2): 889 doi: 10.1002/hep.30214
4
Valeriy V. Tsvetkov, Ivan I. Tokin, Olesya E. Nikitina, Dmitry A. Lioznov. Disorders of lipid metabolism in the liver in patients with chronic viral hepatitisHERALD of North-Western State Medical University named after I.I. Mechnikov 2021; 13(2): 27 doi: 10.17816/mechnikov71418
5
Rafael Käser, Tobias Böttler. Nicht-alkoholische Fettlebererkrankung2022; : 301 doi: 10.1007/978-3-662-62484-5_26
6
Sylvia Drazilova, Jakub Gazda, Martin Janicko, Peter Jarcuska. Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA TherapyCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6150861
7
K V Zhdanov, S S Karyakin, K V Kozlov, D A Gusev, V S Sukachev, A V Saulevich, M V Yaremenko, S N Kizhlo, D M Shahmanov, D Yu Lobzin, M V Kurtukov, M A Dzheriev. Chronic hepatitis С and non-alcoholic fatty liver disease. Main aspects of pathogenesisBulletin of the Russian Military Medical Academy 2018; 20(1): 216 doi: 10.17816/brmma12326
8
Samarth S. Patel, Eiman Nabi, Luis Guzman, Antonio Abbate, Chandra Bhati, Richard T. Stravitz, Trevor Reichman, Scott C. Matherly, Carolyn Driscoll, Hannah Lee, Velimir A. Luketic, Richard K. Sterling, Arun J. Sanyal, Vaishali Patel, Marlon Levy, Mohammad Shadab Siddiqui. Coronary artery disease in decompensated patients undergoing liver transplantation evaluationLiver Transplantation 2018; 24(3): 333 doi: 10.1002/lt.25012
9
David P. Durham, Laura A. Skrip, Robert Douglas Bruce, Silvia Vilarinho, Elamin H. Elbasha, Alison P. Galvani, Jeffrey P. Townsend. The Impact of Enhanced Screening and Treatment on Hepatitis C in the United StatesClinical Infectious Diseases 2016; 62(3): 298 doi: 10.1093/cid/civ894
10
N. Urganci, D. Kalyoncu, S. Geylani-Gulec. Insulin resistance in children with chronic hepatitis C and its association with response to IFN-alpha and ribavirinRevista de Gastroenterología de México (English Edition) 2021; 86(2): 140 doi: 10.1016/j.rgmxen.2020.07.006
11
P. O. Bogomolov, A. O. Bueverov, E. A. Fedosina, V. E. Bakirova, S. V. Koblov. Clinical parallels and experience of antivira l therapy in chronic hepatitis with polycystic ovary syndromeExperimental and Clinical Gastroenterology 2020; 174(2): 71 doi: 10.31146/1682-8658-ecg-174-2-71-79
12
Chia-Chi Wang, Pin-Nan Cheng, Jia-Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangementAlimentary Pharmacology & Therapeutics 2020; 51(2): 216 doi: 10.1111/apt.15575
13
Yun-Cheng Hsieh, Kuei-Chuan Lee, Chien-Wei Su, Ken-Hsin Lan, Teh-Ia Huo, Yuan-Jen Wang, Hui-Chun Huang, Han-Chieh Lin, Chi-Jen Chu, Yi-Hsiang Huang, Ming-Chih Hou. Persistent liver inflammation in chronic hepatitis C patients with advanced fibrosis after direct-acting antivirals induced sustained virological responseJournal of the Chinese Medical Association 2021; 84(5): 472 doi: 10.1097/JCMA.0000000000000517
14
N. Urganci, D. Kalyoncu, S. Geylani-Gulec. Resistencia a la insulina en niños con hepatitis C crónica y su asociación con la respuesta al IFN-alfa y ribavirinaRevista de Gastroenterología de México 2021; 86(2): 140 doi: 10.1016/j.rgmx.2020.07.002
15
Hilla Knobler, Stephen Malnick. Hepatitis C and insulin action: An intimate relationshipWorld Journal of Hepatology 2016; 8(2): 131-138 doi: 10.4254/wjh.v8.i2.131
16
Austin Chan, Keyur Patel, Susanna Naggie. Genotype 3 Infection: The Last Stand of Hepatitis C VirusDrugs 2017; 77(2): 131 doi: 10.1007/s40265-016-0685-x
17
Elisabeth M. Haberl, Thomas S. Weiss, Georg Peschel, Kilian Weigand, Nikolai Köhler, Josch K. Pauling, Jürgen J. Wenzel, Marcus Höring, Sabrina Krautbauer, Gerhard Liebisch, Christa Buechler. Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2021; 22(10): 5297 doi: 10.3390/ijms22105297
18
Moris Sangineto, Rosanna Villani, Francesco Cavallone, Antonino Romano, Domenico Loizzi, Gaetano Serviddio. Lipid Metabolism in Development and Progression of Hepatocellular CarcinomaCancers 2020; 12(6): 1419 doi: 10.3390/cancers12061419
19
Zobair M. Younossi, Maria Stepanova, Mark Sulkowski, Graham R. Foster, Nancy Reau, Alessandra Mangia, Keyur Patel, Norbert Bräu, Stuart K. Roberts, Nezam Afdhal, Fatema Nader, Linda Henry, Sharon Hunt. Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical TrialsClinical Infectious Diseases 2016; 63(8): 1042 doi: 10.1093/cid/ciw496
20
Kumari Anuja, Souvick Roy, Chinmoy Ghosh, Priya Gupta, Surajit Bhattacharjee, Birendranath Banerjee. Prolonged inflammatory microenvironment is crucial for pro-neoplastic growth and genome instability: a detailed reviewInflammation Research 2017; 66(2): 119 doi: 10.1007/s00011-016-0985-3
21
Fabrizio Angius, Luisa Marras, Angela Ingianni, Raffaello Pompei. Emerging and Reemerging Viral Pathogens2020; : 169 doi: 10.1016/B978-0-12-819400-3.00009-0
22
Carolin Lackner. Practical Hepatic Pathology: a Diagnostic Approach2018; : 167 doi: 10.1016/B978-0-323-42873-6.00012-3
23
Uday Kumar Marri, Kumble Seetharama Madhusudhan. Dual-Energy Computed Tomography in Diffuse Liver DiseasesJournal of Gastrointestinal and Abdominal Radiology 2022; 5(02): 094 doi: 10.1055/s-0042-1742432
24
Daniela Gabbia, Marco Roverso, Samantha Sarcognato, Ilaria Zanotto, Nicola Ferri, Francesco Paolo Russo, Maria Guido, Sara Bogialli, Sara De Martin. The Metabolic Activation of Sofosbuvir Is Impaired in an Experimental Model of NAFLDBiology 2022; 11(5): 693 doi: 10.3390/biology11050693
25
Maja Ružić, Rinaldo Pellicano, Milotka Fabri, Francesco Luzza, Luigi Boccuto, Snežana Brkić, Ludovico Abenavoli. Hepatitis C virus-induced hepatocellular carcinoma: a narrative reviewPanminerva Medica 2018; 60(4) doi: 10.23736/S0031-0808.18.03472-9
26
Jinhong Ren, Isabel Ojeda, Maulik Patel, Michael E. Johnson, Hyun Lee. Exploring small molecules with pan-genotypic inhibitory activities against hepatitis C virus NS3/4A serine proteaseBioorganic & Medicinal Chemistry Letters 2019; 29(16): 2349 doi: 10.1016/j.bmcl.2019.06.009
27
Simona Ruta, Costin Cernescu. Injecting drug use: A vector for the introduction of new hepatitis C virus genotypesWorld Journal of Gastroenterology 2015; 21(38): 10811-10823 doi: 10.3748/wjg.v21.i38.10811
28
Tien S Dong, Elizabeth S Aby, Jihane N Benhammou, Jenna Kawamoto, Steven-Huy Han, Folasade P May, Joseph R Pisegna. Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1cWorld Journal of Hepatology 2018; 10(9): 612-621 doi: 10.4254/wjh.v10.i9.612
29
Megan C. Jacobsen, Sara L. Thrower, Rachel B. Ger, Shuai Leng, Laurence E. Court, Kristy K. Brock, Eric P. Tamm, Erik N.K. Cressman, Dianna D. Cody, Rick R. Layman. Multi‐energy computed tomography and material quantification: Current barriers and opportunities for advancementMedical Physics 2020; 47(8): 3752 doi: 10.1002/mp.14241
30
Susanna Naggie, Andrew J. Muir. Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet NeedsAnnual Review of Medicine 2017; 68(1): 345 doi: 10.1146/annurev-med-052915-015720
31
Lohanna STRAUHS-NITSCH, Marcela Ferro CAMPIOLO, Daphne Benatti Gonçalves MORSOLETTO, Alcindo PISSAIA JUNIOR, Claudia Alexandre Pontes IVANTES. CURING HEPATITIS C WITH THE NEW DIRECT ACTING ANTIVIRALS DID NOT IMPROVE INSULIN RESISTANCE AFTER ONE YEARArquivos de Gastroenterologia 2020; 57(3): 267 doi: 10.1590/s0004-2803.202000000-50
32
Jee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Ming-Lung Yu, Wan-Long Chuang. Updates in the management and treatment of HCV genotype 3, what are the remaining challenges?Expert Review of Anti-infective Therapy 2018; 16(12): 907 doi: 10.1080/14787210.2018.1544492
33
Dina G. Tiniakos, Stratigoula Sakellariou. Non-Alcoholic Fatty Liver Disease2020; : 25 doi: 10.1007/978-3-319-95828-6_3
34
Monika Rau, Peter Buggisch, Stefan Mauss, Klaus H. W. Boeker, Hartwig Klinker, Tobias Müller, Albrecht Stoehr, Jörn M. Schattenberg, Andreas Geier, Pavel Strnad. Prognostic impact of steatosis in the clinical course of chronic HCV infection—Results from the German Hepatitis C-RegistryPLOS ONE 2022; 17(6): e0264741 doi: 10.1371/journal.pone.0264741
35
I. Leshchenko, O. Virchenko, O. Gadiliya, T. Falalyeyeva, L. Lazarenko. Сarbohydrate metabolism parameters under the glutamate-induced obesity in rats and concominant correction with probiotic strains of lactobacilli and bifidobacteriaBulletin of Taras Shevchenko National University of Kyiv. Series: Biology 2015; 70(2): 20 doi: 10.17721/1728_2748.2015.70.20-23
36
T. Revuelto Artigas, N. Zaragoza Velasco, X. Gómez Arbones, T. Vidal Ballester, C. Piñol Felis, J.M. Reñe Espinet, A. Betriu Bars. Infección crónica por el virus de la hepatitis C: un factor de riesgo independiente para la ateromatosis subclínicaRevista Clínica Española 2019; 219(6): 293 doi: 10.1016/j.rce.2018.12.007
37
J. F. Waring, E. O. Dumas, S. Abel, E. Coakley, D. E. Cohen, J. Wade Davis, T. Podsadecki, S. Dutta. Serum miR-122 may serve as a biomarker for response to direct acting antivirals: effect of paritaprevir/R with dasabuvir or ombitasvir on miR-122 in HCV-infected subjectsJournal of Viral Hepatitis 2016; 23(2): 96 doi: 10.1111/jvh.12470
38
Gautam Ray. Factors affecting outcome of treatment of chronic hepatitis C: result of an open label study from eastern IndiaTropical Doctor 2016; 46(1): 28 doi: 10.1177/0049475515569519
39
Mazen Noureddin, Micaela M Wong, Tsuyoshi Todo, Shelly C Lu, Arun J Sanyal, Edward A Mena. Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antiviralsWorld Journal of Gastroenterology 2018; 24(11): 1269-1277 doi: 10.3748/wjg.v24.i11.1269
40
Vladimir Alexei Morozov, Sylvie Lagaye. Hepatitis C virus: Morphogenesis, infection and therapyWorld Journal of Hepatology 2018; 10(2): 186-212 doi: 10.4254/wjh.v10.i2.186
41
Reza Taherkhani, Fatemeh Farshadpour. Epidemiology of hepatitis C virus in IranWorld Journal of Gastroenterology 2015; 21(38): 10790-10810 doi: 10.3748/wjg.v21.i38.10790
42
T. Revuelto Artigas, N. Zaragoza Velasco, X. Gómez Arbones, T. Vidal Ballester, C. Piñol Felis, J.M. Reñe Espinet, A. Betriu Bars. Chronic hepatitis C infection: An independent risk factor for subclinical atheromatosisRevista Clínica Española (English Edition) 2019; 219(6): 293 doi: 10.1016/j.rceng.2019.02.008
43
Sanjaya K. Satapathy, Vanessa Kuwajima, Jeffrey Nadelson, Omair Atiq, Arun J. Sanyal. Drug-induced fatty liver disease: An overview of pathogenesis and managementAnnals of Hepatology 2015; 14(6): 789 doi: 10.5604/16652681.1171749
44
Chung-Feng Huang, Jyh-Jou Chen, Ming-Lun Yeh, Ching-I Huang, Ming-Yen Hsieh, Hua-Ling Yang, Chia-Yen Dai, Jee-Fu Huang, Zu-Yau Lin, Shinn-Cherng Chen, Wan-Long Chuang, Yao-Li Chen, Ming-Lung Yu. PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patientsScientific Reports 2015; 5(1) doi: 10.1038/srep11901
45
Ana Claudia Silva Braga, Bruno Moreira Carneiro, Mariana Nogueira Batista, Mônica Mayumi Akinaga, Cíntia Bittar, Paula Rahal, Ratna B. Ray. Heat shock proteins HSPB8 and DNAJC5B have HCV antiviral activityPLOS ONE 2017; 12(11): e0188467 doi: 10.1371/journal.pone.0188467
46
Fabrizio Angius, Angela Ingianni, Raffaello Pompei. Human Herpesvirus 8 and Host-Cell Interaction: Long-Lasting Physiological Modifications, Inflammation and Related Chronic DiseasesMicroorganisms 2020; 8(3): 388 doi: 10.3390/microorganisms8030388
47
Sergio Ferra-Murcia, Antonio Ramón Collado-Romacho, Bruno José Nievas-Soriano, Fernando Reche-Lorite, Tesifón Parrón-Carreño. Real-Life Early Anthropometric, Lipid and Liver Changes after Direct-Acting Antiviral Therapy in PLWHIV with HCV Co-InfectionJournal of Clinical Medicine 2022; 11(9): 2639 doi: 10.3390/jcm11092639